Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is an important component of the pharmaceutical sector. The major global pharmaceutical groups dominate the local industry, although only a small number are engaged in actives manufacturing (i.e. active pharmaceutical ingredients). An increasing number of firms are limiting their Australian involvement to the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to distribution.
As with the global pharmaceutical industry, the local industry is currently contending with the fallout effects associated with the patent cliff... purchase to read more
Industry Report - Industry Investment Chapter
The Pharmaceutical Product Manufacturing industry has a medium level of capital intensity, reflecting the level of capital tied up in manufacturing facilities capable of producing, high-cost, high-technology drugs. In 2014-15, for every dollar that the overall industry spends on capital, $7.80 is spent on wages. Capital labour intensity ratios vary between product segments, with the patented prescription product segment having a considerably higher ratio than the generic and over-the-counter (OTC) product segments.
Falling levels of capital investment growth have recently characterised the industry, with fewer players investing in updating manufacturing capacity or equipment... purchase to read more